Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapyFlorence Pasquier, Xenia Cabagnols, Lise Secardin, et al.
Medecine Sciences : M/S|April 10, 2015
[Properties and biological roles of TET proteins during embryogenesis and in hematopoiesis]Emna Mahfoudhi, Lise Secardin, Laurianne Scourzic, et al.
The Journal of Nutritional Biochemistry|December 28, 2010
Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic miceChristophe Noll, Lamia Raaf, Chris Planque, et al.
DNA Repair|June 13, 2016
TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesisEmna Mahfoudhi, Ibtissam Talhaoui, Xenia Cabagnols, et al.
Stem Cell Research|March 21, 2020
TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cellsLise Secardin, Cintia Elisabeth Gomez Limia, Antonio di Stefano, et al.
Hemasphere|June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative NeoplasmsLise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.
Plos One|September 26, 2013
Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patientsJoseph Saliba, Sofiane Hamidi, Gaëlle Lenglet, et al.
Nature Genetics|August 18, 2015
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignanciesJoseph Saliba, Cécile Saint-Martin, Antonio Di Stefano, et al.
Pageof 1